Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer news2026-02-26T14:52:14+00:00February 26th, 2026|Endpoints News|
Charles River sells its CDMO and European discovery businessesnews2026-02-25T16:22:03+00:00February 25th, 2026|Endpoints News|
AbbVie budgets $380M for obesity and neuroscience API facilities in Chicagonews2026-02-23T16:00:44+00:00February 23rd, 2026|Endpoints News|
Supreme Court tariff ruling lets stand Trump’s authority to target pharma news2026-02-20T18:35:54+00:00February 20th, 2026|Endpoints News|
Novartis to divest India unit to private equity-led consortium for $159M news2026-02-20T12:15:13+00:00February 20th, 2026|Endpoints News|
Sanofi to expand in India; Stada invests $100M in Saudi Arabianews2026-02-19T15:42:43+00:00February 19th, 2026|Endpoints News|
J&J pours $1B into new cell therapy site in Pennsylvanianews2026-02-18T18:30:40+00:00February 18th, 2026|Endpoints News|
Charles River highlights increase in demand as tariff uncertainties fadenews2026-02-18T17:33:30+00:00February 18th, 2026|Endpoints News|
Lilly stockpiles $1.5B worth of weight loss pill ahead of US approvalnews2026-02-13T15:00:35+00:00February 13th, 2026|Endpoints News|
Novo Nordisk to expand Irish factory for Wegovy pillnews2026-02-12T17:55:57+00:00February 12th, 2026|Endpoints News|
